We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
401
Cigna
CI
$76.6B
$2.32M 0.04%
15,839
+2,672
+20% +$394K
XEL icon
402
Xcel Energy
XEL
$51B
$2.31M 0.04%
52,013
+12,169
+31% +$516K
PRTK
403
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.31M 0.04%
+120,000
New +$1.89M
ROP icon
404
Roper Technologies
ROP
$36.3B
$2.29M 0.04%
11,092
+2,820
+34% +$565K
RDUS
405
DELISTED
Radius Health, Inc.
RDUS
$2.28M 0.04%
59,000
-3,000
-5% -$126K
ALDR
406
DELISTED
Alder Biopharmaceuticals
ALDR
$2.27M 0.04%
109,000
+69,000
+173% +$1.53M
PFG icon
407
Principal Financial Group
PFG
$23.6B
$2.25M 0.04%
35,605
+5,289
+17% +$323K
ICE icon
408
Intercontinental Exchange
ICE
$82.4B
$2.25M 0.04%
37,492
+7,959
+27% +$466K
FTV icon
409
Fortive
FTV
$19B
$2.23M 0.04%
58,787
+16,966
+41% +$608K
NKTR icon
410
Nektar Therapeutics
NKTR
$2.39B
$2.23M 0.04%
6,333
-5,334
-46% -$1.2M
KPTI icon
411
Karyopharm Therapeutics
KPTI
$168M
$2.21M 0.04%
11,467
-14,533
-56% -$2.33M
CTSH icon
412
Cognizant
CTSH
$21.5B
$2.19M 0.04%
36,795
+8,357
+29% +$480K
SHG icon
413
Shinhan Financial Group
SHG
$33.6B
$2.18M 0.04%
+52,200
New +$2.12M
CCI icon
414
Crown Castle
CCI
$32.7B
$2.18M 0.04%
+23,081
New +$2.06M
EQIX icon
415
Equinix
EQIX
$107B
$2.17M 0.04%
5,433
+1,492
+38% +$567K
WAT icon
416
Waters Corp
WAT
$36.8B
$2.14M 0.04%
13,669
+2,717
+25% +$406K
ACAD icon
417
Acadia Pharmaceuticals
ACAD
$4.25B
$2.1M 0.04%
+61,000
New +$2.15M
SLF icon
418
Sun Life Financial
SLF
$45.6B
$2.09M 0.04%
57,358
-223,440
-80% -$8.49M
KR icon
419
Kroger
KR
$34.8B
$2.08M 0.04%
70,616
+12,554
+22% +$401K
AGEN
420
Agenus
AGEN
$249M
$2.06M 0.04%
27,905
– –
PAYX icon
421
Paychex
PAYX
$40.4B
$2.06M 0.04%
35,060
+3,298
+10% +$200K
FISV
422
Fiserv Inc
FISV
$27.2B
$2.06M 0.04%
35,764
+7,590
+27% +$426K
MTD icon
423
Mettler-Toledo International
MTD
$26.8B
$2.06M 0.04%
4,298
+652
+18% +$298K
GWPH
424
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.06M 0.04%
17,000
+3,000
+21% +$368K
EXPD icon
425
Expeditors International
EXPD
$22.9B
$2.06M 0.04%
36,372
+5,258
+17% +$288K
15 16
17
18 19

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.